We are proud to announce Anemocyte’s participation in the Cell & Gene Meeting on the Mesa, taking place in Phoenix, Arizona, from October 6 to 8, 2025.
This premier event gathers over 2,000 senior leaders from across the cell and gene therapy ecosystem – scientists, biotech innovators, investors, and global stakeholders – offering a unique platform to exchange ideas and accelerate the development of advanced therapies.
The agenda features panels, workshops, and company presentations covering key topics such as commercialization pathways, innovative funding models, and the future of gene editing, mRNA, and tissue engineering. With more than 5,000 partnering meetings expected, it represents one of the most impactful opportunities for dialogue and collaboration in the sector.
For Anemocyte, being present at Meeting on the Mesa is not just about showcasing our capabilities in pDNA and mRNA manufacturing – it is about actively contributing to a community that shares our vision: enabling the therapies of tomorrow through scientific excellence, solid manufacturing expertise, and collaborative innovation.
We look forward to connecting with partners, clients, and peers in Phoenix to continue building the future of advanced therapies together.
